Autonomix Medical, Inc. Common Stock
AMIXAutonomix Medical, Inc. (AMIX) is a medical device company that develops and markets innovative solutions aimed at improving minimally invasive surgical procedures. Focused on addressing unmet clinical needs, the company offers advanced surgical technologies designed to enhance precision, safety, and patient outcomes in various medical fields.
Company News
Autonomix Medical announced a warrant inducement agreement where an investor will exercise outstanding warrants to purchase 428,731 shares at $6.00 per share, generating approximately $2.6 million in gross proceeds. In return, the company will issue new Series D-1 and D-2 warrants with a $5.75 exercise price. The transaction is expected to close ...
Autonomix Medical will present two podium sessions at the Transcatheter Cardiovascular Therapeutics Annual Scientific Conference, highlighting their first-in-human clinical study on transvascular energy delivery for pancreatic cancer pain mitigation.
Autonomix Medical, a medical device company developing innovative nerve-targeted treatment technologies, will present at the Webull Financial Corporate Connect Webinar Series on August 21, 2025, discussing their microchip-based intravascular nerve sensing platform.
Autonomix Medical, Inc. (NASDAQ: AMIX) announced the grant of a stock option to a new non-executive employee as an inducement to their employment. The option has a 10-year term and vests over four years, subject to continued service.
Autonomix Medical, Inc. has been granted a U.S. patent for its technology that aims to treat cancerous tumors and cancer-related pain. The company's preclinical studies have shown promising results in reducing metastases and tumor mass, and it plans to further explore the potential of its technology to slow pancreatic cancer growth and metastasis.
